Skip to contentN
NU Skin Enterprises, Inc.
N
NUSNU Skin Enterprises, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$370.32M$370.32Mderived−16.9% vs Q4 2024 Net Income$14.49M$14.49MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NU Skin Enterprises, Inc. · CIK 1021561 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$261,981,000−6.1% Operating Incomederived$23,244,000N/M Operating Cash Flowderived$16,621,000−35.5% Free Cash Flowderived$5,861,000−55.6% Margins · derivedGross margin70.7%+8.1 pt vs Q4 2024
Operating margin6.3%+18.2 pt vs Q4 2024
Net margin3.9%+12.0 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 13, 2026 · 44 d after period end